#222 CHANGES IN BRAIN ACTIVITY ON FUNCTIONAL MAGNETIC RESONANCE IMAGING DURING SACRAL NEUROMODULATION FOR OVERACTIVE BLADDER

Presenter: Howard Goldman

#223 Functional Brain Connectivity In Older Women With Urgency Urinary Incontinence

Presenter: Becky Clarkson

#224 IS OVERACTİVE BLADDER MICROVASCULATURE DISEASE A COMPONENT OF SYSTEMIC ATHEROSCLEOROSIS?

Presenter: Ahmet Özgür Yeniel

#225 SN003, a corticotropin-releasing factor receptor type-1 (CRF1) antagonist, attenuates depressive-like behavior and detrusor overactivity symptoms induced by 13-cis-retinoic acid administration in rats

Presenter: Pawel Miotla

#226 Uropathogens are capable of intracellular growth in exfoliated urothelial cells isolated from women.

Presenter: Kylie J Mansfield

#227 Does an alteration in the balance between pro-inflammatory and anti-inflammatory cytokines explain why patients with refractory DO are more prone to recurrent UTI?

Presenter: Kylie J Mansfield

#228 Effects of High-Salt Diet and Polyuria on the Bladder

Presenter: Abubakr Mossa

#229 IS OVERACTIVE BLADDER ANOTHER FACET OF THE METABOLIC SYNDROME? : A cross-sectional study among Japanese men and women.

Presenter: Yoshitaka Aoki

#230 Developing a mapping model between two commonly used patient-reported outcome instruments: the IPSS and OAB-V8

Presenter: Kevin Carlson

#231 Gathering requirements with users for the development of an assistive mobile phone application to support bladder training.

Presenter: Joanne Booth

#232 The Characterization of Overactive Bladder Phenotypes Using Electronic Data Capture

Presenter: Jerry Blaivas

#233 Identification of each threshold of four OAB-symptoms severity to impact significantly on QOL suggested by the visual analogue scale to evaluate QOL or bother specific to each symptom

Presenter: Atsuko Fujihara